Fintel reports that on November 13, 2025, Needham reiterated coverage of Lucid Diagnostics (NasdaqCM:LUCD) with a Buy recommendation.
Analyst Price Forecast Suggests 244.59% Upside
As of November 9, 2025, the average one-year price target for Lucid Diagnostics is $3.82/share. The forecasts range from a low of $2.52 to a high of $8.40. The average price target represents an increase of 244.59% from its latest reported closing price of $1.11 / share.
See our leaderboard of companies with the largest price target upside.
The projected annual revenue for Lucid Diagnostics is 278MM, an increase of 6,220.30%. The projected annual non-GAAP EPS is -1.19.
What is the Fund Sentiment?
There are 135 funds or institutions reporting positions in Lucid Diagnostics. This is an increase of 62 owner(s) or 84.93% in the last quarter. Average portfolio weight of all funds dedicated to LUCD is 0.02%, an increase of 89.80%. Total shares owned by institutions increased in the last three months by 42.44% to 26,324K shares.
What are Other Shareholders Doing?
Masters Capital Management holds 2,727K shares representing 2.09% ownership of the company. No change in the last quarter.
Standard Life Aberdeen holds 2,500K shares representing 1.91% ownership of the company.
VTSMX - Vanguard Total Stock Market Index Fund Investor Shares holds 2,142K shares representing 1.64% ownership of the company. In its prior filing, the firm reported owning 613K shares , representing an increase of 71.40%. The firm increased its portfolio allocation in LUCD by 140.74% over the last quarter.
Geode Capital Management holds 1,674K shares representing 1.28% ownership of the company. In its prior filing, the firm reported owning 1,577K shares , representing an increase of 5.78%. The firm decreased its portfolio allocation in LUCD by 54.93% over the last quarter.
IWM - iShares Russell 2000 ETF holds 1,558K shares representing 1.19% ownership of the company.
Fintel is one of the most comprehensive investing research platforms available to individual investors, traders, financial advisors, and small hedge funds.
Our data covers the world, and includes fundamentals, analyst reports, ownership data and fund sentiment, options sentiment, insider trading, options flow, unusual options trades, and much more. Additionally, our exclusive stock picks are powered by advanced, backtested quantitative models for improved profits.
This story originally appeared on Fintel.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
